Arsenic Trioxide Shows Synergistic Anti-Myeloma Effects When Combined with Bortezomib and Melphalan In Vitro and Helps Overcome Resistance of Multiple Myeloma Cells to These Treatments in Vivo.
Year: 2004
Type: article
Source: Blood
Authors: Richard A. Campbell, Haiming Chen, Daocheng Zhu, Janice C. Santos, Benjamin Bonavida, Shen Pang, Jonathan Said, James R. Berenson
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2993410908
